Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
about
Oral deferiprone for iron chelation in people with thalassaemiaMore pieces to the iron chelation puzzle.Advances in iron chelation therapy: transitioning to a new oral formulation.Design of iron chelators with therapeutic application.Hepatocellular carcinoma in thalassemia: A critical reviewComparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials.Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examinationToward optimizing the use of deferasirox: potential benefits of combined use with deferoxamineCost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveOverview of iron chelation therapy with desferrioxamine and deferiprone.Beta-thalassemia.Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone.Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicities.An update on disordered iron metabolism and iron overload.Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom.The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.Iron chelation in thalassemia: time to reconsider our comfort zones.Frequency of neutropenia among Turkish and Syrian pediatric thalassemia patients under deferiprone monotherapy.Recent advances in β-thalassemiasSequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study.Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
P2860
Q24200309-E49110E2-D276-407C-B6CF-F6D6940CC02BQ33349435-D5046D94-7E53-49D8-B276-FE04C4B0AB14Q33879123-E2FE0B5A-F307-432E-96E6-451C1C280E8BQ34258805-FD8F5AE2-E4E4-4A01-9FEE-A81D57E94B90Q34391592-84327C19-053D-47FC-B60A-86D7F726F58BQ35077670-84E2948F-55AA-43B0-A445-03BA56DD0F50Q35434460-2D4D02EE-9850-49AB-95E5-CBB7BC240409Q36498403-42E4AC86-51ED-4E05-BB3A-170C25176694Q37132320-589E2363-6E2D-4144-A270-79DF2FD956F7Q37650457-DB1CF023-E189-4498-8F2E-D556B221A3C0Q37680651-0AEC2213-67A9-4122-A326-689B9CD1D7ABQ37762809-C0AAD4A4-BF86-440B-977D-9E011E994346Q37765561-DB31C89B-C8F2-484C-ABEF-0EF4915FED97Q37791615-AB78E4DD-377E-4998-97CA-1B27985E2998Q38540491-15EB969E-4828-4AB3-A33F-00F09A093C6CQ38797297-4147F510-9AA9-4E57-9EB4-FECC90B0604AQ38810873-43EBE333-93FC-46DB-B608-CEF5F70F7302Q39260564-EF0E9BCF-1103-487F-BA98-3E9D6838F790Q39782885-7BB1B72C-2CC8-44ED-A70C-929B888D8DC2Q40776444-5831BDA8-A311-4EA8-BCB9-32CC42BB0680Q41973193-BD8A39A2-34EE-443C-9667-C67B846C3B4DQ42601757-DFF784E3-DBCA-4E27-82BE-F13F883A1C3DQ42859202-7EFEC0B7-D5B2-43C4-8663-61DB6C21EB41Q47671705-A300018F-C91D-40D2-B7E0-75E8570EB45CQ56389520-7D609546-916D-495A-95FF-1D10D70C5539
P2860
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Long-term sequential deferipro ...... : a randomized clinical trial.
@en
Long-term sequential deferipro ...... : a randomized clinical trial.
@nl
type
label
Long-term sequential deferipro ...... : a randomized clinical trial.
@en
Long-term sequential deferipro ...... : a randomized clinical trial.
@nl
prefLabel
Long-term sequential deferipro ...... : a randomized clinical trial.
@en
Long-term sequential deferipro ...... : a randomized clinical trial.
@nl
P2093
P1476
Long-term sequential deferipro ...... : a randomized clinical trial.
@en
P2093
Alberto Morabito
Aldo Filosa
Alessandra Quota
Alessia Pepe
Angela Vitrano
Calogera Gerardi
Carmelo Fidone
Carmelo Magnano
Crocetta Argento
Domenico Giuseppe D'Ascola
P304
P356
10.1111/J.1365-2141.2009.07609.X
P407
P577
2009-02-19T00:00:00Z